| Literature DB >> 25905687 |
Noriko Komoto1, Takahisa Nakane, Sachiko Matsumoto, Shusuke Hashimoto, Osamu Shirota, Setsuko Sekita, Masanori Kuroyanagi.
Abstract
A methanol extract of the leaves of Cephalotaxus harringtonia var. nana and its ethyl acetate (EtOAc)-soluble fraction demonstrated strong antitumor activity against A549 and HT-29 cell lines. The EtOAc-soluble fraction was purified by column chromatography and high-performance liquid chromatography (HPLC) using a reverse-phase column to yield three novel acyl flavonoids and a biflavonoid, along with 15 other known compounds that included flavonoids, biflavonoids, and other phenolics. The structures of the new compounds were elucidated using spectral data from HR-MS and NMR, including two-dimensional NMR studies, as (2R,3R)-3-O-eicosanoyltaxifolin (1), (2R,3R)-3-O-docosanoyltaxifolin (2), (2R,3R)-3-O-tetracosanoyltaxifolin (3), and 6-methyl-4',7,7″-tri-O-methylamentoflavone (4). The isolated compounds, including the known compounds, were tested for possible antitumor activity; some of the biflavones were found to be active. The potent antitumor activity of the extract was attributed to Cephalotaxus alkaloids, such as homoharringtonine (20).Entities:
Mesh:
Substances:
Year: 2015 PMID: 25905687 DOI: 10.1007/s11418-015-0912-x
Source DB: PubMed Journal: J Nat Med ISSN: 1340-3443 Impact factor: 2.343